These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

439 related articles for article (PubMed ID: 15498636)

  • 21. Prognostic factors for patients with node-negative gastric cancer: Can extended lymph node dissection have a survival benefit?
    Park SS; Park JM; Kim JH; Kim WB; Lee J; Kim SJ; Kim CS; Mok YJ
    J Surg Oncol; 2006 Jul; 94(1):16-20. PubMed ID: 16788938
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Surgical outcome of curative resection in patients with Borrmann type IV gastric carcinoma with particular reference to the extent of lymph node metastasis.
    Kikuchi S; Hiki Y; Tsutsumi O; Kobayashi N; Tsukamoto H; Shimao H; Sakakibara Y; Kakita A
    Hepatogastroenterology; 2000; 47(33):890-2. PubMed ID: 10919055
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Therapeutic effects of transabdominal radical total gastrectomy on cardiac cancer: analysis of 56 cases].
    Wu T; Wan YL; Rong L; Pan YS; Wang X; Liu YC
    Zhonghua Yi Xue Za Zhi; 2007 Jun; 87(21):1474-7. PubMed ID: 17785085
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prognostic and clinical evaluation of patients with T2 gastric cancer.
    Komatsu S; Ichikawa D; Kurioka H; Kan K; Shioaki Y; Ueshima Y; Hamashima T; Lee CJ; Ikeda E; Ueda Y; Otsuji E; Oka T; Yamagishi H
    Hepatogastroenterology; 2005; 52(63):965-8. PubMed ID: 15966242
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Clinicopathological features and long-term results of surgical therapy of early gastric cancer].
    Hou PF; Zhang XF; Zheng ZW
    Zhonghua Wei Chang Wai Ke Za Zhi; 2007 Jan; 10(1):53-6. PubMed ID: 17253175
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Application of minimally invasive treatment for early gastric cancer.
    Hyung WJ; Cheong JH; Kim J; Chen J; Choi SH; Noh SH
    J Surg Oncol; 2004 Mar; 85(4):181-5; discussion 186. PubMed ID: 14991872
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The value of D1 lymphadenectomy as prognostic marker in gastric cancer.
    Diaz de Liaño A; Ciga MA; Oteiza F; Aizcorbe M; Cobo F; Trujillo R; Nuin MA
    Hepatogastroenterology; 2001; 48(39):895-8. PubMed ID: 11462951
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Appropriate gastric resection with lymph node dissection for early gastric cancer.
    Borie F; Plaisant N; Millat B; Hay JM; Fagniez PL;
    Ann Surg Oncol; 2004 May; 11(5):512-7. PubMed ID: 15078634
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mixed-histologic-type submucosal invasive gastric cancer as a risk factor for lymph node metastasis: feasibility of endoscopic submucosal dissection.
    Hanaoka N; Tanabe S; Mikami T; Okayasu I; Saigenji K
    Endoscopy; 2009 May; 41(5):427-32. PubMed ID: 19418397
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Multivariate prognostic study on large gastric cancer.
    Shiraishi N; Sato K; Yasuda K; Inomata M; Kitano S
    J Surg Oncol; 2007 Jul; 96(1):14-8. PubMed ID: 17582596
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparison of surgical results of D2 versus D3 gastrectomy (para-aortic lymph node dissection) for advanced gastric carcinoma: a multi-institutional study.
    Kunisaki C; Akiyama H; Nomura M; Matsuda G; Otsuka Y; Ono H; Nagahori Y; Hosoi H; Takahashi M; Kito F; Shimada H
    Ann Surg Oncol; 2006 May; 13(5):659-67. PubMed ID: 16538414
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Factors related to lymph node metastasis and the feasibility of endoscopic mucosal resection for treating poorly differentiated adenocarcinoma of the stomach.
    Park YD; Chung YJ; Chung HY; Yu W; Bae HI; Jeon SW; Cho CM; Tak WY; Kweon YO
    Endoscopy; 2008 Jan; 40(1):7-10. PubMed ID: 18210339
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The prognostic value of N-ratio in patients with gastric cancer: validation in a large, multicenter series.
    Marchet A; Mocellin S; Ambrosi A; de Manzoni G; Di Leo A; Marrelli D; Roviello F; Morgagni P; Saragoni L; Natalini G; De Santis F; Baiocchi L; Coniglio A; Nitti D;
    Eur J Surg Oncol; 2008 Feb; 34(2):159-65. PubMed ID: 17566691
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Diffuse type advanced gastric cancer showing dismal prognosis is characterized by deeper invasion and emerging peritoneal cancer cell: the latest comparative study to intestinal advanced gastric cancer.
    Yamashita K; Sakuramoto S; Katada N; Futawatari N; Moriya H; Hirai K; Kikuchi S; Watanabe M
    Hepatogastroenterology; 2009; 56(89):276-81. PubMed ID: 19453074
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Clinicopathological features and prognosis of different gastric carcinoid subtypes].
    Liang JW; Zhou ZX; Liu Q; Bai XF; Zhao P
    Zhonghua Zhong Liu Za Zhi; 2008 Nov; 30(11):866-9. PubMed ID: 19173835
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Survival in early gastric cancer: multivariate analysis on 72 consecutive cases.
    Pacelli F; Doglietto GB; Alfieri S; Carriero C; Malerba M; Crucitti PF; Caprino P; Crucitti F
    Hepatogastroenterology; 1999; 46(26):1223-8. PubMed ID: 10370696
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Risk factors and prognosis of node-positive cervical carcinoma].
    Feng SY; Zhang YN; Liu JG
    Ai Zheng; 2005 Oct; 24(10):1261-6. PubMed ID: 16219145
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Advanced gastric cancer with early cancer macroscopic appearance: is it worthy of D2 lymphadenectomy?
    Sun Z; Wang ZN; Zhu GL; Huang BJ; Li K; Xu Y; Li DM; Xu HM
    Ann Surg Oncol; 2010 May; 17(5):1278-90. PubMed ID: 20058192
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Lymph node metastasis in gastric cancer: result of D2 dissection.
    Methasate A; Trakarnsanga A; Akaraviputh T; Chinsawangwathanakol V; Lohsiriwat D
    J Med Assoc Thai; 2010 Mar; 93(3):310-7. PubMed ID: 20420105
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Metastatic lymph node ratio is an independent prognostic factor in gastric cancer.
    Asoglu O; Karanlik H; Parlak M; Kecer M; Muslumanoglu M; Igci A; Ozmen V; Gulluoglu M; Kapran Y
    Hepatogastroenterology; 2009; 56(91-92):908-13. PubMed ID: 19621727
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.